CR20120632A - SOLID COMPOSITIONS - Google Patents

SOLID COMPOSITIONS

Info

Publication number
CR20120632A
CR20120632A CR20120632A CR20120632A CR20120632A CR 20120632 A CR20120632 A CR 20120632A CR 20120632 A CR20120632 A CR 20120632A CR 20120632 A CR20120632 A CR 20120632A CR 20120632 A CR20120632 A CR 20120632A
Authority
CR
Costa Rica
Prior art keywords
pharmaceutically acceptable
solid compositions
solid
hydrophilic polymer
compound
Prior art date
Application number
CR20120632A
Other languages
Spanish (es)
Inventor
Bernd Liepold
Karin Rosenbalt
Peter Holig
Rajeev Gokhale
Leena Prasad
Jonathan Miller
Eric A Schmitt
John B Morris
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Priority to CR20120632A priority Critical patent/CR20120632A/en
Publication of CR20120632A publication Critical patent/CR20120632A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones solidas que comprenden el compuesto I amorfo. Una dispersión sólida de la presnte invención tambien contiene un polímero hidrofílico farmacéuticamente aceptable y un agente tensioactivo farmacéuticamente aceptable. El compuesto I puede fomularse en una dispersión sólida amorfa que comprende un polímero hidrofílico farmacéuticamente aceptable y preferiblemente un agente tensioactivo farmacéuticamente aceptable.Solid compositions comprising the amorphous compound I. A solid dispersion of the present invention also contains a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant. Compound I can be formulated into a solid amorphous dispersion comprising a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant.

CR20120632A 2012-12-12 2012-12-12 SOLID COMPOSITIONS CR20120632A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR20120632A CR20120632A (en) 2012-12-12 2012-12-12 SOLID COMPOSITIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR20120632A CR20120632A (en) 2012-12-12 2012-12-12 SOLID COMPOSITIONS

Publications (1)

Publication Number Publication Date
CR20120632A true CR20120632A (en) 2013-03-19

Family

ID=48672860

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20120632A CR20120632A (en) 2012-12-12 2012-12-12 SOLID COMPOSITIONS

Country Status (1)

Country Link
CR (1) CR20120632A (en)

Similar Documents

Publication Publication Date Title
CO6640208A2 (en) Solid compositions
ECSP13012382A (en) SOLID COMPOSITIONS
MX2014008008A (en) Solid compositions comprising an hcv inhibitor.
SI2811998T1 (en) Parasiticidal oral veterinary compositions comprising systemically acting active agents, methods and uses thereof
AR081681A1 (en) METHODS AND COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF b-GALACTOCEREBROSIDASA
UY35298A (en) FORMULATION IN SOLID DISPERSION OF AN ANTIVIRAL COMPOUND
CO6852097A2 (en) Environmental friendly coalescence agents
EA201071378A1 (en) DRONEDARON FOR PREVENTION OF PERMANENT ATRIAL FIBRILLATION
IT1404931B1 (en) OPHTHALMIC COMPOSITIONS FOR THE ADMINISTRATION OF LIPO-SOLUBLE ACTIVE PRINCIPLES.
CO6741223A2 (en) Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
CO7160079A2 (en) Liquid racecadotillo compositions
SA515361092B1 (en) Racecadotril lipid compositions
PH12014502858A1 (en) Racecadotril lipid compositions
EP3074000A4 (en) Suspension compositions of physiologically active phenolic compounds&methods of making and using the same
WO2013123046A3 (en) Cathode buffer materials and related devices and methods
CA2875305C (en) Fbxo3 inhibitors
SMT201500235B (en) Formulation comprising phenylaminopyrimidine derivative as active agent
AR091739A1 (en) COMPOSITIONS AND METHODS TO REDUCE CARDIOMETABOLIC RISK
CL2015000847A1 (en) Oil formulations with binders
MX2023003000A (en) Modified release formulations of viloxazine.
CR20120632A (en) SOLID COMPOSITIONS
AR093813A1 (en) FINAFLOXACINE SUSPENSION COMPOSITIONS
CR20130631A (en) SOLID COMPOSITIONS
AR083796A1 (en) ANTIMICROBIAL SYNERGISTIC COMPOSITION OF 1,2-BENZISOTIAZOLIN-3-ONA AND TRIS (HYDROXIMETHYL) NITROMETHANE
AR095131A1 (en) COMBINED FORMULATION OF TWO ANTIVIRAL COMPOUNDS